PT1556371E - Derivados de benzimidazole e sua utilizacao como pro-farmacos de inibadores da bomba de protoes. - Google Patents

Derivados de benzimidazole e sua utilizacao como pro-farmacos de inibadores da bomba de protoes.

Info

Publication number
PT1556371E
PT1556371E PT03765694T PT03765694T PT1556371E PT 1556371 E PT1556371 E PT 1556371E PT 03765694 T PT03765694 T PT 03765694T PT 03765694 T PT03765694 T PT 03765694T PT 1556371 E PT1556371 E PT 1556371E
Authority
PT
Portugal
Prior art keywords
pump inhibitors
pharmacies
benzimidazole
pro
derivatives
Prior art date
Application number
PT03765694T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Winston Pharmateuticals Llc
Univ California
Us Gov Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winston Pharmateuticals Llc, Univ California, Us Gov Veterans Affairs filed Critical Winston Pharmateuticals Llc
Publication of PT1556371E publication Critical patent/PT1556371E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
PT03765694T 2002-07-19 2003-07-15 Derivados de benzimidazole e sua utilizacao como pro-farmacos de inibadores da bomba de protoes. PT1556371E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39745902P 2002-07-19 2002-07-19

Publications (1)

Publication Number Publication Date
PT1556371E true PT1556371E (pt) 2006-09-29

Family

ID=30771064

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03765694T PT1556371E (pt) 2002-07-19 2003-07-15 Derivados de benzimidazole e sua utilizacao como pro-farmacos de inibadores da bomba de protoes.

Country Status (23)

Country Link
US (3) US6897227B2 (US06897227-20050524-C00065.png)
EP (1) EP1556371B1 (US06897227-20050524-C00065.png)
JP (1) JP4463103B2 (US06897227-20050524-C00065.png)
KR (2) KR100788778B1 (US06897227-20050524-C00065.png)
AT (1) ATE323695T1 (US06897227-20050524-C00065.png)
AU (1) AU2003259154B2 (US06897227-20050524-C00065.png)
BR (1) BR0312802A (US06897227-20050524-C00065.png)
CA (1) CA2492718C (US06897227-20050524-C00065.png)
CO (1) CO5690576A2 (US06897227-20050524-C00065.png)
DE (1) DE60304726T2 (US06897227-20050524-C00065.png)
DK (1) DK1556371T3 (US06897227-20050524-C00065.png)
ES (1) ES2263028T3 (US06897227-20050524-C00065.png)
HK (1) HK1079207A1 (US06897227-20050524-C00065.png)
IL (1) IL166371A0 (US06897227-20050524-C00065.png)
MX (1) MXPA05000657A (US06897227-20050524-C00065.png)
NO (1) NO20050801L (US06897227-20050524-C00065.png)
NZ (1) NZ538221A (US06897227-20050524-C00065.png)
PL (1) PL375255A1 (US06897227-20050524-C00065.png)
PT (1) PT1556371E (US06897227-20050524-C00065.png)
RU (1) RU2292342C2 (US06897227-20050524-C00065.png)
TW (1) TW200502231A (US06897227-20050524-C00065.png)
WO (1) WO2004009583A2 (US06897227-20050524-C00065.png)
ZA (1) ZA200501116B (US06897227-20050524-C00065.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
NZ544173A (en) * 2003-07-15 2009-04-30 Alevium Pharmaceuticals Inc Process for preparing isomerically pure prodrugs of benzimidazole derivative proton pump inhibitors
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
CA2557471A1 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Methods and compositions for the intravenous administration of compounds related to proton pump inhibitors
JP2007523163A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物
EP1722794A1 (en) * 2004-03-11 2006-11-22 Allergan, Inc. Methods and compositions for the treatment of conditions related to gastric acid secretion
PT1740571E (pt) 2004-04-28 2009-09-02 Hetero Drugs Ltd Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
WO2007073301A1 (en) * 2005-12-23 2007-06-28 Astrazeneca Ab Benzoimidazole derivatives as prodrugs of proton pump inhibitors
US20070265311A1 (en) * 2006-01-10 2007-11-15 Rubino Mark P Therapeutic Salt Compositions and Methods
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
US20070293543A1 (en) * 2006-06-19 2007-12-20 Edward Lee THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z
WO2008036211A1 (en) * 2006-09-19 2008-03-27 Alevium Pharmaceuticals, Inc. Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
KR20090035195A (ko) * 2007-10-05 2009-04-09 엘지전자 주식회사 플라즈마 디스플레이 장치
WO2009044976A1 (en) * 2007-10-05 2009-04-09 Lg Electronics Inc. Plasma display device
KR100895333B1 (ko) * 2007-11-01 2009-05-07 엘지전자 주식회사 플라즈마 디스플레이 패널의 구동 방법 및 그를 이용한플라즈마 디스플레이 장치
WO2012051036A1 (en) 2010-10-11 2012-04-19 Merck Sharp & Dohme Corp. Quinazolinone-type compounds as crth2 antagonists
WO2012087872A1 (en) 2010-12-23 2012-06-28 Merck Sharp & Dohme Corp. Quinolines and aza-quinolines as crth2 receptor modulators
ES2635030T3 (es) 2010-12-23 2017-10-02 Merck Sharp & Dohme Corp. Quinoxalinas y aza-quinoxalinas como moduladores del receptor CRTH2
CA2973370A1 (en) * 2015-01-09 2016-07-14 The Regents Of The University Of California Compositions and methods for treating gastrointestinal infections
CN108997177A (zh) * 2018-09-04 2018-12-14 邵阳学院 一种微波促进n-苯磺酰基硝基苯胺类化合物合成的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US430042A (en) * 1890-06-10 Valve
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US4758597A (en) * 1987-05-15 1988-07-19 University Patents, Inc. Carenadiol and derivatives
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5045522A (en) * 1990-03-27 1991-09-03 Phillips Petroleum Company Absorption composition comprising zinc titanate for removal of hydrogen sulfide from fluid streams
CA2083606C (en) * 1990-06-20 2001-08-21 Arne Elof Brandstrom Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
NZ288609A (en) * 1994-06-10 1998-12-23 Byk Gulden Lomberg Chem Fab Substituted (4-thiopyridinyl) methylthio-benzimidazole (or 1h-imidazo-[2,3-b]-pyridine) and medicaments
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
DE69905171T2 (de) 1998-08-10 2003-11-20 Winston Pharmaceuticals Llc Ne Prodrugs für proton-pump-inhibitoren
KR100687194B1 (ko) * 1998-08-12 2007-02-27 길리애드 사이언시즈, 인코포레이티드 1,3-옥사티올란 뉴클레오시드의 제조 방법
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6599167B2 (en) * 2000-09-27 2003-07-29 Glenn Waltz Game call holder and amplifying device
WO2002030920A1 (fr) * 2000-10-12 2002-04-18 Takeda Chemical Industries, Ltd. Composes derives de benzimidazole, leur procede de production et leur utilisation

Also Published As

Publication number Publication date
AU2003259154C1 (en) 2004-02-09
CA2492718C (en) 2010-12-21
KR100822981B1 (ko) 2008-04-16
KR100788778B1 (ko) 2007-12-27
DE60304726D1 (de) 2006-05-24
WO2004009583A2 (en) 2004-01-29
IL166371A0 (en) 2006-01-16
KR20070005029A (ko) 2007-01-09
EP1556371B1 (en) 2006-04-19
AU2003259154B2 (en) 2006-12-07
MXPA05000657A (es) 2005-08-19
DK1556371T3 (da) 2006-08-21
HK1079207A1 (en) 2006-03-31
PL375255A1 (en) 2005-11-28
CO5690576A2 (es) 2006-10-31
DE60304726T2 (de) 2007-08-09
ES2263028T3 (es) 2006-12-01
AU2003259154A1 (en) 2004-02-09
EP1556371A2 (en) 2005-07-27
CA2492718A1 (en) 2004-01-29
TW200502231A (en) 2005-01-16
NO20050801L (no) 2005-02-15
JP2005536519A (ja) 2005-12-02
BR0312802A (pt) 2005-04-19
JP4463103B2 (ja) 2010-05-12
ATE323695T1 (de) 2006-05-15
KR20050047078A (ko) 2005-05-19
US20050143423A1 (en) 2005-06-30
RU2292342C2 (ru) 2007-01-27
NZ538221A (en) 2006-11-30
US20050182101A1 (en) 2005-08-18
US6897227B2 (en) 2005-05-24
US20040102484A1 (en) 2004-05-27
RU2005105564A (ru) 2005-10-10
WO2004009583A3 (en) 2004-03-18
ZA200501116B (en) 2006-11-29

Similar Documents

Publication Publication Date Title
PT1556371E (pt) Derivados de benzimidazole e sua utilizacao como pro-farmacos de inibadores da bomba de protoes.
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
HN2002000247A (es) Derivados de sulfonamida
BR0308967A (pt) Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação
DK0991407T3 (da) Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
UY27761A1 (es) Derivados de acil-4-carboxifenilurea, procedimientos para su preparcción y su uso.
NO20025590D0 (no) Fenylglycin-derivater
HRP20090017T3 (en) 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
NO20062548L (no) Intranasale blandinger
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
RS52315B (en) DIARYLMETHYL PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
ECSP088621A (es) Derivados de triazoloanilinopirimidina para uso como agentes antivirales
BRPI0516057A (pt) derivados de indol como inibidores da ciclase de adenilato solúvel
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
GT200800066A (es) Derivados de 9-cloro-15-deoxiprostaglandina, procedimiento para su preparacion y su uso como medicamento.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
ATE325115T1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
DE60324703D1 (de) Barbitursäure derivaten.
ITMI20000293A0 (it) Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica
DE60003074D1 (de) Fusidinsäure-derivate
PT1220844E (pt) Derivados de benzimidazole substituidos como arilssulfonamida e sua utilizacao como inibidores de triptase